These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3075284)

  • 1. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
    Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
    Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
    [No Abstract]   [Full Text] [Related]  

  • 2. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
    Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
    [No Abstract]   [Full Text] [Related]  

  • 3. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
    Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
    Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of relapsed and refractory acute myeloid leukemia in adults.
    Lazzarino M; Morra E; Alessandrino EP; Merante S; Bernasconi P; Bonfichi M; Caldera D; Bernasconi C
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():121-3. PubMed ID: 2653487
    [No Abstract]   [Full Text] [Related]  

  • 5. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
    Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
    Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
    Wells RJ; Adams MT; Alonzo TA; Arceci RJ; Buckley J; Buxton AB; Dusenbery K; Gamis A; Masterson M; Vik T; Warkentin P; Whitlock JA;
    J Clin Oncol; 2003 Aug; 21(15):2940-7. PubMed ID: 12885813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
    Brunet S; Esteve J; Berlanga J; Ribera JM; Bueno J; Martí JM; Bargay J; Guardia R; Juliá A; Granena A; Montserrat E; Sierra J;
    Haematologica; 2004 Aug; 89(8):940-9. PubMed ID: 15339677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination chemotherapy with low doses of cytarabine and etoposide for high risk myelodysplastic syndromes and their leukemic stage. A pilot study.
    Kuriya S; Murai K; Miyairi Y; Utsugisawa T; Narigasawa Y; Ito T; Shimosegawa K; Ishida Y
    Cancer; 1996 Aug; 78(3):422-6. PubMed ID: 8697386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase-three trial comparing daunorubicin or idarubicin combined with cytosine arabinoside in acute myelogenous leukemia.
    Vogler WR; Velez-Garcia E; Omura G; Raney M
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):21-4. PubMed ID: 2648581
    [No Abstract]   [Full Text] [Related]  

  • 10. [The results of a multicenter cooperative study on treating acute myeloid leukemias in adults].
    Savchenko VG; Parovichnikova EN; Kliasova GA; Isaev VG; Kulikov SM; Tikhonova LIu; Cherepanova VV; Rekhtman GB; Medvedeva NV; Kaporskaia TS
    Ter Arkh; 1994; 66(7):11-7. PubMed ID: 7985120
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary results of an induction combination regimen including fractionated anthracycline.
    Krieger O; Bernhart M; Fiedler E; Kasparu H; Weber E; Lutz D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():66. PubMed ID: 2627610
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of treatment with an intensive combination induction regimen containing idarubicin in children with acute myeloblastic leukemia: preliminary report of the Argentine Group for Treatment of Acute Leukemia.
    Sackmann-Muriel F; Fernández-Barbieri MA; Santarelli MT; Matus-Ridley M; Rosso A; Negri-Aranguren P; Cerutti I; Gomel M; Kvicala R
    Semin Oncol; 1993 Dec; 20(6 Suppl 8):34-8. PubMed ID: 8290970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose cytarabine in acute myelogenous leukemia.
    Zittoun R
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():38-42. PubMed ID: 2653516
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
    Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
    Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ["A-triple-V" in refractory or relapsed acute myelocytic leukemia].
    Miyawaki S; Nemoto K; Wakamatsu R; Baba N; Yashiro K; Uchida S; Nakura M; Karasawa M; Takada M; Tanaka H
    Rinsho Ketsueki; 1987 Jan; 28(1):34-9. PubMed ID: 3471982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].
    Miyazaki Y
    Rinsho Ketsueki; 2009 Aug; 50(8):611-6. PubMed ID: 19915375
    [No Abstract]   [Full Text] [Related]  

  • 17. Idarubicin plus cytarabine as first-line treatment of acute nonlymphoblastic leukemia.
    Lambertenghi-Deliliers G; Annaloro C; Cortelezzi A; Cortellaro M; Della Volpe A; Maiolo AT; Mozzana R; Pogliani E; Pozzoli E; Polli EE
    Semin Oncol; 1989 Feb; 16(1 Suppl 2):16-20. PubMed ID: 2928806
    [No Abstract]   [Full Text] [Related]  

  • 18. [The first Russian trial of treating patients with acute nonlymphoblastic leukemias with novantrone combined with cytosar].
    Volkova MA; Kaletin GI
    Ter Arkh; 1992; 64(7):18-21. PubMed ID: 1440359
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot study.
    Tallman MS; Lee S; Sikic BI; Paietta E; Wiernik PH; Bennett JM; Rowe JM
    Cancer; 1999 Jan; 85(2):358-67. PubMed ID: 10023703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy with DATV regimen in treatment of adult acute nonlymphocytic leukemia.
    Lou FD; Zhou Q; Liu HC; Meng FY; Wang YZ
    Chin Med J (Engl); 1993 Nov; 106(11):876-8. PubMed ID: 8143502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.